News
COR benefits from strong specialty and GLP-1 demand, but Q3 results may face pressure from international weakness.
ABC News medical correspondent Dr. Darien Sutton talks about GLP-1 drugs and access for teens and young adults in the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback